| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.310 | None | 1.000 | 5 | 0 | 2007 | 2014 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1991 | 2019 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.350 | None | 1.000 | 5 | 0 | 2003 | 2014 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.370 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
disease | 0.370 | None | 0.400 | 5 | 0 | 1999 | 2004 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.530 | None | 1.000 | 4 | 0 | 1994 | 2012 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 1979 | 1994 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.400 | None | 1.000 | 4 | 0 | 2004 | 2014 | |||||||||
|
long intergenic non-protein coding RNA 271 | 0.769 | 0.192 |
|
disease | 0.330 | None | 0.667 | 3 | 0 | 2006 | 2010 | |||||||||
|
dendritic cell associated nuclear protein | 0.839 | 0.154 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2010 | 2013 | |||||||||
|
dendritic cell associated nuclear protein | 0.839 | 0.154 |
|
disease | 0.330 | None | 0.667 | 3 | 0 | 2010 | 2013 | |||||||||
|
microRNA 137 | 0.513 | 0.846 |
|
disease | 0.350 | None | 0.667 | 3 | 0 | 2012 | 2019 | |||||||||
|
microRNA 346 | 0.631 | 0.615 |
|
disease | 0.350 | None | 1.000 | 3 | 0 | 2009 | 2017 | |||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2007 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2012 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2012 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2010 | 2012 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2012 | |||||||||
|
endogenous retrovirus group W member 4 | 0.686 | 0.615 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2001 | 2006 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2012 | 2016 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2004 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1988 | 1990 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2009 | 2010 | |||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2008 | 2019 |